0000939767-23-000019 Sample Contracts

FOURTH AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT
Collaboration and License Agreement • February 7th, 2023 • Exelixis, Inc. • Biological products, (no disgnostic substances)

This Fourth Amendment to the Collaboration and License Agreement (the “Fourth Amendment”) is entered into as of October 11, 2022 (the “Fourth Amendment Effective Date”) by and between Exelixis, Inc., a Delaware company having an address at 1851 Harbor Bay Parkway, Alameda, CA 94502, USA (“Exelixis”) and Ipsen Pharma SAS, a French corporation having an address at 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France (“Licensee”). Exelixis and Licensee may be referred to herein individually as a “Party” or collectively as the “Parties.”

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.